Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Bowles

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 15, 2014
Distress among caregivers of phase I trial participants: a cross-sectional studyElizabeth R Kessler, Angela Moss, S Gail Eckhardt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 24, 2017
Metastatic nasopharyngeal carcinoma: Patterns of care and survival for patients receiving chemotherapy with and without local radiotherapyChad G Rusthoven, Ryan M Lanning, Bernard L Jones, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 9, 2018
The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non-Small Cell Lung Cancer and Rate of Central Nervous System Progression on CrizotinibTejas Patil, Derek E Smith, Paul A Bunn, et al.
Investigational New Drugs|April 22, 2015
Pharmacokinetic drug-drug interaction study of the angiopoietin-1/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumorsJennifer R Diamond, Benjamin Wu, Neeraj Agarwal, et al.
Journal of Clinical Pharmacology|December 23, 2024
Population Pharmacokinetic Model of Platinum Disposition in Cancer Patients Receiving Cisplatin and Randomized to 5-HT<sub>3</sub> Antagonist Antiemetic DrugsLauren E Thompson, Avisek Ghimire, Xia Wen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2014
A randomized, phase 2 trial of Docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic non-small-cell lung cancerBenjamin Levy, Alexander Spira, Daniel Becker, et al.
Oral Oncology|January 17, 2015
A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancerAntonio Jimeno, Julie E Bauman, Charles Weissman, et al.
European Journal of Clinical Pharmacology|September 17, 2018
Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patientsMustafa E Ibrahim, Cara Chang, Yichun Hu, et al.
Molecular Carcinogenesis|December 22, 2018
Inter- and intra-tumor heterogeneity of SMAD4 loss in head and neck squamous cell carcinomasAriel L Hernandez, Ying Wang, Hilary L Somerset, et al.
Clinical Colorectal Cancer|April 28, 2016
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal CarcinomaDaniel W Bowles, Mark Kochenderfer, Allen Cohn, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 15, 2014
Distress among caregivers of phase I trial participants: a cross-sectional studyElizabeth R Kessler, Angela Moss, S Gail Eckhardt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 24, 2017
Metastatic nasopharyngeal carcinoma: Patterns of care and survival for patients receiving chemotherapy with and without local radiotherapyChad G Rusthoven, Ryan M Lanning, Bernard L Jones, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 9, 2018
The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non-Small Cell Lung Cancer and Rate of Central Nervous System Progression on CrizotinibTejas Patil, Derek E Smith, Paul A Bunn, et al.
Investigational New Drugs|April 22, 2015
Pharmacokinetic drug-drug interaction study of the angiopoietin-1/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumorsJennifer R Diamond, Benjamin Wu, Neeraj Agarwal, et al.
Journal of Clinical Pharmacology|December 23, 2024
Population Pharmacokinetic Model of Platinum Disposition in Cancer Patients Receiving Cisplatin and Randomized to 5-HT<sub>3</sub> Antagonist Antiemetic DrugsLauren E Thompson, Avisek Ghimire, Xia Wen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2014
A randomized, phase 2 trial of Docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic non-small-cell lung cancerBenjamin Levy, Alexander Spira, Daniel Becker, et al.
Oral Oncology|January 17, 2015
A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancerAntonio Jimeno, Julie E Bauman, Charles Weissman, et al.
European Journal of Clinical Pharmacology|September 17, 2018
Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patientsMustafa E Ibrahim, Cara Chang, Yichun Hu, et al.
Molecular Carcinogenesis|December 22, 2018
Inter- and intra-tumor heterogeneity of SMAD4 loss in head and neck squamous cell carcinomasAriel L Hernandez, Ying Wang, Hilary L Somerset, et al.
Clinical Colorectal Cancer|April 28, 2016
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal CarcinomaDaniel W Bowles, Mark Kochenderfer, Allen Cohn, et al.
Pageof 8